Table 2.
Step | Variables | R2 | ΔR2 | B | SE B | β |
---|---|---|---|---|---|---|
Step 1 | .31 | .31* | ||||
Gender | 18.13 | 6.73 | .57* | |||
Age a | −4.17 | 8.25 | −.10 | |||
Step 2 | .33 | .03 | ||||
Gender | 18.75 | 6.73 | .59* | |||
Age | −0.52 | 9.56 | −.01 | |||
Prior trauma PTSD severity | 0.50 | 0.64 | .19 | |||
Step 3 | .40 | .06 | ||||
Gender | 22.23 | 7.18 | .70* | |||
Age | −2.81 | 9.58 | −.07 | |||
Prior trauma PTSD severity | 0.63 | 0.64 | .24 | |||
Treatment condition b | 8.87 | 7.13 | .28 | |||
Significance of the regression model, F (4, 15) = 2.46, p = .09. | ||||||
Step 4 | .61** | .21* | ||||
Gender | 7.00 | 8.10 | .22 | |||
Age | −2.18 | 7.96 | −.05 | |||
Prior trauma PTSD severity | .35 | .54 | .13 | |||
Treatment condition | −7.12 | 8.26 | −.22 | |||
Treatment × Gender | 31.82 | 11.46 | .72* |
Note. PTSD = Posttraumatic stress disorder
Consistent with prior psychophysiological research examining age/gender differences (Gunnar et al., 2009), age was dichotomized within gender such that girls over 12 years of age and boys over 14 years of age were coded as “1.”
Treatment was coded such that propranolol was “1” and placebo was “0”.
p < .05.
p < .01.